Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial-Reference-Cited by-同舟云学术

Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial

Published:2012-02 Issue:2 Volume:13 Page:163-171
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Chen Lei,Hu Chao-Su,Chen Xiao-Zhong,Hu Guo-Qing,Cheng Zhi-Bin,Sun Yan,Li Wei-Xiong,Chen Yuan-Yuan,Xie Fang-Yun,Liang Shao-Bo,Chen Yong,Xu Ting-Ting,Li Bin,Long Guo-Xian,Wang Si-Yang,Zheng Bao-Min,Guo Ying,Sun Ying,Mao Yan-Ping,Tang Ling-Long,Chen Yu-Ming,Liu Meng-Zhong,Ma Jun

Publisher

Elsevier BV

Subject

Oncology

Reference30 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Nasopharyngeal carcinoma treated by radical radiotherapy alone: ten year experience of a single institution;Yi;Int J Radiat Oncol Biol Phys,2006

3. American Joint Committee on Cancer Staging Manual;Greene,2002

4. Re-evaluation of 6th edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement based on magnetic resonance imaging;Mao;Int J Radiat Oncol Biol Phys,2009

5. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup Study 0099;Al-Sarraf;J Clin Oncol,1998

Cited by 468 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy of adjuvant chemotherapy in patients with different midpoint-radiotherapy Epstein-Barr virus DNA plasma loads;Oral Oncology;2024-09

2. Short-term versus long-term metronomic adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: A propensity score-matched real-world study;Oral Oncology;2024-09

3. Determining the optimal timing of adjuvant chemotherapy initiation after concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma;ESMO Open;2024-09

4. Proton pump inhibitors may increase the risk of cisplatin-induced acute kidney injury in patients with nasopharyngeal carcinoma: a prospective cohort study;Scientific Reports;2024-08-13

5. Mecapegfilgrastim for the prophylaxis of chemotherapy‐induced neutropenia in locally advanced nasopharyngeal carcinoma: A prospective phase II clinical study;Head & Neck;2024-08-11